Hemodynamic and metabolic effects of intravenous formyl-methionyl-leucyl-phenylalanine (FMLP) in rabbits

In Vivo

Volumn 11, Issue 2, 1997, Pages 133-139

  Magni, Jonsson ^c   Tzanela, Marinella ^a   Kolbeck, Ralph C ^c   Mccormick, James R ^b  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b LEXINGTON VA MEDICAL CENTER   (United States)

^c NONE

Author keywords

Chemotactic factors; Hypotension

Indexed keywords

BICARBONATE; CHEMOTACTIC PEPTIDE; COMPLEMENT COMPONENT C5A [DEARGININE]; CYCLOPHOSPHAMIDE; FORMYLMETHIONYLLEUCYLPHENYLALANINE; LACTIC ACID;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BICARBONATE BLOOD LEVEL; BLOOD PH; CENTRAL VENOUS PRESSURE; CONTROLLED STUDY; DOSE RESPONSE; HEMODYNAMICS; HYPOTENSION; INTRAVENOUS DRUG ADMINISTRATION; LACTATE BLOOD LEVEL; METABOLISM; NEUTROPENIA; NONHUMAN; RABBIT; SYSTEMIC VASCULAR RESISTANCE; THROMBOCYTOPENIA;

EID: 12644304210     PISSN: 0258851X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Schiffman E, Showell HV, Corcoran BA, Ward PA, Smith E, Becker EL: The isolation and partial characterization of neutrophil chemotactic factors from Escherichia coli. J Immunol 114: 1831-1837, 1975.
2. Aswanikumar S, Corcoran B, Schiffman E: Demonstration of a receptor on rabbit neutrophils for chemotactic peptides. Biochem Biophys Res Commun 74: 810-817, 1977.
3. Becker, E.L: The formylpeptide receptor of the neutrophil. A search and conserve operation. Am J Pathol 129: 1624, 1987.
4. Snyderman R, Fudman EJ: Demonstration of a chemotactic factor receptor on macrophages. J Immunol 124: 2754-2757, 1980.
5. Schubert T, Muller WE: N-formyl-methionyl-leucyl-phenylalanine induced accumulation of inositol phosphates indicates the presence of oligopeptide chemoattractant receptors on human lymphocytes. Febs Lett 257: 174-176, 1989.
6. Hoover RL, Folger R, Haering WA, Ware BA, Karnovsky MJ: Adhesion of leukocytes to endothelium: roles of divalent cations, surface charge, chemotactic agents and substrate. J Cell Sci 45: 73-86 1980.
7. Naccache PH, Showell HJ, Becker EL, Sha'afi RI: Transport of sodium, potassium, and calcium across rabbit polymorphonuclear leukocyte membranes. Effect of chemotactic factor. J Cell Biol 73: 428-444, 1977.
8. O'Flaherty JT, Ward PA: Chemotactic factors and the neutrophil. Semin Hematol 16: 163-174 1979.
9. Keller HU, Zimmerman A, Cottier H: Crawling -like movements, adhesion to solid substrate and chemokinesis of neutrophil granulocytes. J Cell Sci 64: 89-106, 1983.
10. Niedel JE, Kahane I, Cuatrecasas P: Receptor-mediated internalization of fluorescent chemotactic peptide by human neutrophils. Science 205: 1412-1414, 1979.
11. Schiffman E, Corcoran BA, Wahl SM: N- formylmethionyl peptides as chemoattractants for leukocytes. Proc Nat Acad Sci USA 72: 1059-1062, 1975.
12. Boxer LA, Yoder M, Bonsib S, Schmidt M, Ho P, Jersild R, Baehner RL: Effects of a chemotactic factor, N-formyl-methionyl peptide, on adherence, superoxide anion generation, phagocytosis and microtubule assembly of human polymorphonuclear leukocytes. J Lab Clin Med 93: 506-510, 1979.
13. Armour CL, Black JL, Jonsop RA, Vincenc KS, Berent N: Formylpeptide induced contraction of human airways in vitro. J Appl Physiol 60: 141-146, 1989.
14. Crowell, R.E., D.E. Van Epps, and W.P. Reed: Responses of isolated pulmonary arteries to synthetic peptide F-Met-Leu-Phe. Am J Physiol 257: H107-H112, 1989.
15. Gillespie MN, Booth DC, Friedman BJ, Cunningam MR, Jay M, Demaria A: FMLP provokes coronary vasoconstriction and myocardial ischemia in rabbits. Am J Physiol 257: H481-486, 1988.
16. Hamel B, Ford-Huthinson AW, Lord A, Cirino M: Bronchoconstriction induced by N-formyl-methionyl-leucyl-phenylalanine in the guinea pig; involvement of arachidonic acid metabolites. Prostaglandins 28: 43-56, 1984.
17. Kolbeck, R.C., Cherry S, and McCormick JR: Chemotactin induced alteration in rabbit vascular smooth muscles contractility. Clin Res 830A (Abstract), 1985.
18. Marasco, WA, Fantone JC, Ward PA. Spasmogenic activity of chemotactic N-formylated oligopeptides: Identity of structurefunction relationships for chemotactic and spasmogenic activities. Proc Natl Acad Sci USA 79: 7470-7473, 1982.
19. Smith JK, McCormick JR, Elguindi AS: Contraction of human and guinea pig airway by a chemotactic peptide. Chest 88: 28 (abstract), 1985.
20. O' Flaherty JT, Showell HJ, Ward P: Neutropenia induced by systemic infusion of chemotactic factors. J Immunol 118: 1586-1589, 1977.
21. Colditz, IG, Movat HZ: Kinetics of neutrophil accumulation in acute inflammatory lesions induced by chemotaxins and chemotaxinigens. J Immunol 133: 2169-2173
22. Berent N, Armour CL, Black JL. Formyl-methionyl-leucyl-phenylalanine causes bronchoconstriction in rabbits. Agents Actions 77: 466-471, 1986.
23. Peters MJ, Breslin ABX, Berend N: The effect of anticholinergic and beta-agonist pretreatment on bronchoconstriction induced by N-formyl-methionyl-leucyl-phenylalanine. Eur Respir J 2: 946-949, 1989.
24. Peters MJ, Breslin AB, Kemp AS, Chu J, Berend N. Hematological effects of inhalation of N-formyl-methionyl-leucyl-phenylalanine in man. Thorax 47: 284-287, 1992.
25. Jonsson M, McCormick JR. Granulocytopenia and shock induced by f-met-leu-phe in the rabbit. Chest 82: 235 (abstract), 1982.
26. Saito H, Matsuo M, Naminohira S, Sakai T, Kitagawa H, Hirata AA: Effect of N-Formyl-L-Methionyl-L-Leucyl-L-Phenylalanine and its analogues on blood pressure. J Pharm Dyn 6: 141-144, 1983.
27. McCormick JR, Jonsson M: The effect of corticosteroids and indomethacin on chemotactin-mediated hypotension in the rabbit. Clin Res 31: 826 (abstract), 1983.
28. Catravas JD, White RE: Kinetics of pulmonary angiotensin-converting enzyme and 5′-nucleotidase in vivo. J Appl Physiol 57: 1173-1181, 1984.
29. Keller HU, Sorkin S: Studies on chemotaxis: V. On the chemotactic effect of bacteria. Int Arch Allergy 31: 505-517, 1967.
30. Stimler NP, Brocklehurst WE, Bloor CM, Hugli TE: Anaphylatoxin-mediated contraction of guinea pig lung strips: a nonhistamine tissue response. J Immunol 126: 2258-2261, 1981.
31. O' Flaherty JT, Showell HJ, Kreutzer DL, Ward PA, Becker EL: Inhibition of in vivo and in vitro neutrophil responses to chemotactic factors by a competitive antagonist. J Immunol 120: 1326-1332, 1978.
32. Goeffier E, Joseph D, Prevost MC, Vargaftig BB: Platelet leucocyte interaction: activation of rabbit platelets by FMLP-stimulated neutrophils. Br J Pharmacol 92: 393-406, 1987.
33. Del Mashio A, Evangelista V, Rajtar G, Chen ZM, Cerletti C, De Gaetano G: Platelet activation by polymorphonuclear leukocytes exposed to chemotactic agents. Am J Physiol 27: H870-H879, 1990.
34. Bureau MF, De Clerk F, Lefort J, Arreto CD, Vargaftig BB: Thromboxane A2 accounts for bronchoconstriction but not for platelet sequestration and mjcrovascular albumin exchanges induced by FMLP in the quinea pig lung. J Pharmacol Exper Ther 260: 832-840, 1992.
35. Tanaka H, Bradley GD, Leudendistel LJ: Mechanisms of pulmonary vasoconstriction induced by chemotactic peptide FMLP in isolated rabbit lungs. J Appl Physiol 72: 1549-1556, 1992.
36. Bode SM, Kuhn M, Forstermann U: Chemotactic peptide FMLP contracts human coronary arteries via cyclooxygenase products. Am J Physiol 258: H848-H853, 1990.
37. Doherty DE, Haslett C, Tonnesen MG, Henson PM: Human monocyte adherence: A primary effect of chemotactic factors on the monocyte to stimulate adherence to human endothelium. J Immunol 138: 1762-1771, 1987.
38. Kolbeck RC, McCormick JR: Arachidonic acid metabolites and chemotactininduced hypotension in rabbits. Clin Res 34: 316A (Abstract), 1986.
39. Kontos HA: Oxygen radicals in cerebral vascular injury. Circ Res 57: 508-516, 1985.
40. Laurindo FR, Goldstein RE, Davenport NJ, Ezra D, Feuerstein GZ: Mechanisms of hypotension produced by platelet-activating factor. J Appl Physiol 66: 2681-2690, 1989.
41. Maderazo EG, Breux SP, Woronick CL: Protective effects of ibuprofen and methylprednisolone on chemotactic factor-induced transcutaneous hypoxia. J Pharmacol Exper Therap 238: 453-456, 1986.